Stock listing
Metagenomi Therapeutics, Inc.
Selected listing: MGX · NASDAQ · USD · US
Metagenomi Therapeutics, Inc. (NASDAQ:MGX), Health Technology. Latest release Sep 1, 2026: Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st…
- Ticker
- NASDAQ:MGX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. is a public company traded under the ticker MGX in the American market. Metagenomi focuses on developing innovative gene editing technologies to advance therapeutic solutions.
Latest news from Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
September 1, 2026
Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
August 10, 2026
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
May 28, 2026
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 11, 2026
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 15, 2026
Events
Replays
Metagenomi Therapeutics, Inc. (MGX) Q3 2025 Earnings Call
Tue, Nov 11, 2025 · 04:30 PM ET
Watch
Research Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. company profile
View the public company page for Metagenomi Therapeutics, Inc. on 6ix.
Metagenomi Therapeutics, Inc. news
Read company news and market updates connected to Metagenomi Therapeutics, Inc..
Metagenomi Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Metagenomi Therapeutics, Inc..